Recruiting
Phase 2
Phase 3

Fianlimab & Cemiplimab

Sponsor:

Regeneron Pharmaceuticals

Code:

NCT05785767

Conditions

Advanced Non-Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

fianlimab

cemiplimab

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information